Home›Companies›Biotech & Pharma›Ember LifeSciences

Ember LifeSciences, Inc.

Reusable temperature-controlled shipping boxes for pharmaceutical companies and healthcare providers.

Updated Nov 11, 2026·Latest SEC filing Aug 20, 2026·Suggest an edit

About Ember LifeSciences

Ember LifeSciences is a private company based in Westlake Village, California, incorporated in 2022 in Delaware. It has reported $32,166,448 raised in one offering on Form D since March 2026. Its chief executive is Clayton Alexander.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 16, 2025Mar 3, 2026amended Aug 20, 2026$32,166,448of $50.0M target50$643KEquityRule 506(b)Form D/A ↗1 earlier filing

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ember LifeSciences's Form D filed Aug 20, 2026.

Clayton Alexander
Clayton Alexander
Founder and CEO, director
Also an executive officer and director at Ember Technologies.
BB
Brian Bejarano
President and General
AH
Ann Hyllengren
Chief Financial Officer
JD
James DeNaut
Director
TW
Timothy White
Director
Also a director at Wealth and an executive officer and promoter at Dunes Point Capital.
MK
Michael Kaufmann
Director
Also a director at Prescribe FIT.

Sources

  1. SECEmber LifeSciences, Inc. Form D, filed Mar 3, 2026
  2. SECEmber LifeSciences, Inc. filing history
  3. CompanyPrivacy notice
  4. PressAlfresa alliance announcement
  5. CompanyAbout Ember LifeSciences
  6. CompanySeries A investment announcement
  7. PressEmber LifeSciences spinout announcement
  8. PressAnn Hyllengren appointment